Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts

Journal of Experimental Medicine

Volumn 197, Issue 1, 2003, Pages 77-85

  Watzl, Carsten ^a,b   Long, Eric O ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Activation; Inhibitory receptor; Natural killer cell; Raft; Tyrosine phosphorylation

Indexed keywords

ACTIN; ANTIGEN; CD244 ANTIGEN; HLA ANTIGEN CLASS 1; INHIBITOR PROTEIN; LIGAND; LIPID; NATURAL KILLER CELL INHIBITORY RECEPTOR; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; ANTIGEN BINDING; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOLYSIS; CYTOSKELETON; HUMAN; HUMAN CELL; MEMBRANE BINDING; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LIPID INTERACTION; PROTEIN PHOSPHORYLATION; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TARGET CELL;

ACTINS; ANTIGENS, CD; CELL FRACTIONATION; CYTOSKELETON; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MEMBRANE MICRODOMAINS; PHOSPHORYLATION; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC;

EID: 0037244127     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20020427     Document Type: Article

References (49)

1. Biron, C.A., and L. Brossay. 2001. NK cells and NKT cells in innate defense against viral infections. Curr. Opin. Immunol. 13:458-464.
2. Soloski, M.J. 2001. Recognition of tumor cells by the innate immune system. Curr. Opin. Immunol. 13:154-162.
3. Long, E.O., D.F. Barber, D.N. Burshtyn, M. Faure, M. Peterson, S. Rajagopalan, V. Renard, M. Sandusky, C.C. Stebbins, N. Wagtmann, et al. 2001. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158). Immunol. Rev. 181:223-233.
4. Davis, D.M., I. Chiu, M. Fassett, G.B. Cohen, O. Mandelboim, and J.L. Strominger. 1999. The human natural killer cell immune synapse. Proc. Natl. Acad. Sci. USA. 96:15062-15067.
5. Eriksson, M., J.C. Ryan, M.C. Nakamura, and C.L. Sentman. 1999. Ly49A inhibitory receptors redistribute on natural killer cells during target cell interaction. Immunology. 97: 341-347.
6. Vyas, Y.M., K.M. Mehta, M. Morgan, H. Maniar, L. Butros, S. Jung, J.K. Burkhardt, and B. Dupont. 2001. Spatial organization of signal transduction molecules in the NK cell immune synapses during MHC class I-regulated noncytolytic and cytolytic interactions. J. Immunol. 167:4358-4367.
7. Lou, Z.K., D. Jevremovic, D.D. Billadeau, and P.J. Leibson. 2000. A balance between positive and negative signals in cytotoxic lymphocytes regulates the polarization of lipid rafts during the development of cell-mediated killing. J. Exp. Med. 191:347-354.
8. Fassett, M.S., D.M. Davis, M.M. Valter, G.B. Cohen, and J.L. Strominger. 2001. Signaling at the inhibitory natural killer cell immune synapse regulates lipid raft polarization but not class I MHC clustering. Proc. Natl. Acad. Sci. USA. 98: 14547-14552.
9. Simons, K., and D. Toomre. 2000. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1:31-39.
10. Dykstra, M., A. Cherukuri, and S.K. Pierce. 2001. Rafts and synapses in the spatial organization of immune cell signaling receptors. J. Leukoc. Biol. 70:699-707.
11. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M.C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19:197-223.
12. Lanier, L.L. 2001. On guard-activating NK cell receptors. Nat. Immunol. 2:23-27.
13. Boles, K.S., S.E. Stepp, M. Bennett, V. Kumar, and P.A. Mathew. 2001. 2B4 (CD244) and CS1: novel members of the CD2 subset of the inmmnoglobulin superfamily molecules expressed on natural killer cells and other leukocytes. Immunol. Rev. 181:234-249.
14. Bottino, C., M. Falco, S. Parolini, E. Marcenaro, R. Augugliaro, S. Sivori, E. Landi, R. Biassoni, L.D. Notarangelo, L. Moretta, et al. 2001. GNTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr-virus-infected B cells in X-linked lymphoproliferative disease. J. Exp. Med. 194:235-246.
15. Vitale, M., M. Falco, R. Castriconi, S. Parolini, R. Zambello, G. Semenzato, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta. 2001. Identification of NKp80, a novel triggering molecule expressed by human NK cells. Eur. J. Immunol. 31:233-242.
16. Sutherland, C.L., N.J. Chalupny, and D. Cosman. 2001. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions. Immunol. Rev. 181:185-192.
17. Bauer, S., V. Groh, J. Wu, A. Steinle, J.H. Phillips, L.L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science. 285:727-729.
18. Latchman, Y., P.F. McKay, and H. Reiser. 1998. Identification of the 2B4 molecule as a counter-receptor for CD48. J. Immunol. 161:5809-5812.
19. Brown, M.H., K. Boles, P.A. Van der Merwe, V. Kumar, P.A. Mathew, and A.N. Barclay. 1998. 2B4, the natural killer and T cell inmmnoglobulin superfamily surface protein, is a ligand for CD48. J. Exp. Med. 188:2083-2090.
20. Nakajima, H., and M. Colonna. 2000. 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism. Hum. Immunol. 61:39-43.
21. Valiante, N.M., and G. Trinchieri. 1993. Identification of a novel signal transduction surface molecule on human cytotoxic lymphocytes. J. Exp. Med. 178:1397-1406.
22. Nakajima, H., M. Celia, H. Langen, A. Friedlein, and M. Colonna. 1999. Activating interactions in human NK cell recognition: the role of 2B4-CD48. Eur. J. Immunol. 29: 1676-1683.
23. Tangye, S.G., S. Lazetic, E. Woollatt, G.R. Sutherland, L.L. Lanier, and J.H. Phillips. 1999. Cutting edge: Human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J. Immunol. 162:6981-6985.
24. Watzl, C., C.C. Stebbins, and E.O. Long. 2000. Cutting edge: NK cell inhibitory receptors prevent tyrosine phosphorylation of the activation receptor 2B4 (CD244). J. Immunol. 165:3545-3548.
25. Sivori, S., S. Parolini, M. Falco, E. Marcenaro, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta. 2000. 2B4 functions as a co-receptor in human NK cell activation. Eur. J. Immunol. 30:787-793.
26. Faure, M., and E.O. Long. 2002. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J. Immunol. 168:6208-6214.
27. Parolini, S., C. Bottino, M. Falco, R. Augugliaro, S. Giliani, R. Franceschini, H.D. Ochs, H. Wolf, J.Y. Bonnefoy, R. Biassoni, et al. 2000. X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J. Exp. Med. 192: 337-346.
28. Bottino, C., R. Augugliaro, R. Castriconi, M. Nanni, R. Biassoni, L. Moretta, and A. Moretta. 2000. Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells. Eur. J. Immunol. 30:3718-3722.
29. Chuang, S.S., P.R. Kumaresan, and P.A. Mathew. 2001. 2B4 (CD244)-mediated activation of cytotoxicity and IFN-gamma release in human NK cells involves distinct pathways. J. Immunol. 167:6210-6216.
30. Burshtyn, D.N., and E.O. Long. 1997. Regulation through inhibitory receptors: lessons from natural killer cells. Trends Cell Biol. 7:473-479.
31. Burshtyn, D.N., A.M. Scharenberg, N. Wagtmann, S. Rajagopalan, K. Berrada, T. Yi, J.P. Kinet, and E.O. Long. 1996. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity. 4:77-85.
32. Wagtmann, N., S. Rajagopalan, C.C. Winter, M. Peruzzi, and E.O. Long. 1995. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity. 3:801-809.
33. Cohen, G.B., R.T. Gandhi, D.M. Davis, O. Mandelboim, B.K. Chen, J.L. Strominger, and D. Baltimore. 1999. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity. 10:661-671.
34. Kubin, M.Z., D.L. Parshley, W. Din, J.Y. Waugh, T. Davis-Smith, C.A. Smith, B.M. Macduff, R.J. Armitage, W. Chin, L. Cassiano, et al. 1999. Molecular cloning and biological characterization of NK cell activation-inducing ligand, a counterstructure for CD48. Eur. J. Immunol. 29:3466-3477.
35. Rajagopalan, S., and E.O. Long. 1998. Zinc bound to the killer cell-inhibitory receptor modulates the negative signal in human NK cells. J. Immunol. 161:1299-1305.
36. Winter, C.C., and E.O. Long. 1997. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J. Immunol. 158:4026-4028.
37. Villalba, M., K. Bi, F. Rodriguez, Y. Tanaka, S. Schoenberger, and A. Altman. 2001. Vav1/Rac-dependent actin cytoskeleton reorganization is required for lipid raft clustering in T cells. J. Cell Biol. 155:331-338.
38. Urbanik, E., and B.R. Ware. 1989. Actin filament capping and cleaving activity of cytochalasins B, D, E, and H. Arch. Biochem. Biophys. 269:181-187.
39. Spector, I., N.R. Shochet, Y. Kashman, and A. Groweiss. 1983. Latrunculins: novel marine toxins that disrupt microfilament organization in cultured cells. Science. 219:493-495.
40. Holzinger, A. 2001. Jasplakinolide. An actin-specific reagent that promotes actin polymenzation. Methods Mol. Biol. 161: 109-120.
41. Tangye, S.G., J.H. Phillips, L.L. Lanier, and K.E. Nichols. 2000. Cutting edge: Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J. Immunol. 165:2932-2936.
42. Nakajima, H., M. Cella, A. Bouchon, H.L. Grierson, J. Lewis, C.S. Duckett, J.I. Cohen, and M. Colonna. 2000. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. Eur. J. Immunol. 30:3309-3318.
43. Benoit, L., X. Wang, H.F. Pabst, J. Dutz, and R. Tan. 2000. Defective NK cell activation in X-linked lymphoproliferative disease. J. Immunol. 165:3549-3553.
44. Vitale, M., C. Bottino, S. Sivori, L. Sanseverino, R. Castriconi, E. Marcenaro, R. Augugliaro, L. Moretta, and A. Moretta. 1998. NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187:2065-2072.
45. Sivori, S., D. Pende, C. Bottino, E. Marcenaro, A. Pessino, R. Biassoni, L. Moretta, and A. Moretta. 1999. NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. Eur. J. Immunol. 29:1656-1666.
46. Zhang, W.G., R.P. Trible, and L.E. Samelson. 1998. LAT palmitoylation: Its essential role in membrane microdomain targeting and tyrosine phosphorylation during T cell activation. Immunity. 9:239-246.
47. Klem, J., P.C. Verrett, V. Kumar, and J.D. Schatzle. 2002. 2B4 is constitutively associated with linker for the activation of T cells in glycolipid-enriched microdomains: properties required for 2B4 lytic function. J. Immunol. 169:55-62.
48. Dietrich, J., M. Cella, and M. Colonna. 2001. Ig-like transcript 2 (ILT2)/leukocyte Ig-like receptor 1 (LIR1) inhibits TCR signaling and actin cytoskeleton reorganization. J. Immunol. 166:2514-2521.
49. Acuto, O., and D. Cantrell. 2000. T cell activation and the cytoskeleton. Annu. Rev. Immunol. 18:165-184.